# Magnetic Resonance Fingerprinting Guided Extended Resection in Glioblastomas

> **NCT06455189** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Case Comprehensive Cancer Center** · enrollment: 114 (estimated)

## Conditions studied

- Glioblastoma
- Brain Tumor

## Interventions

- **OTHER:** Control Group - Standard of care neurosurgical resection
- **PROCEDURE:** MRF/MRI infiltration guidance for extended resection

## Key facts

- **NCT ID:** NCT06455189
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12
- **Primary completion:** 2029-06-01
- **Final completion:** 2029-12-31
- **Target enrollment:** 114 (ESTIMATED)
- **Last updated:** 2025-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06455189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06455189, "Magnetic Resonance Fingerprinting Guided Extended Resection in Glioblastomas". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06455189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*